You are here > Volunteers > Current Trials


To get notified of upcoming trials via Facebook visit our Q-Pharm Facebook page and 'like us'!

HAVE YOU BEEN RECEIVING OUR TRIAL NOTIFICATION EMAILS? If you are registered on our volunteer database to receive trial notifications via email, please add the following email address to your safe senders list to ensure that you receive the notifications:

For further information on any of the trials listed below please contact Q-Pharm Recruitment on 1300 QPHARM (1300 774 276 voicemail) or email us at

Please note all trials are conducted at our clinic located in the Clive Berghofer Cancer Research Centre, Level 5, 300c Herston Road HERSTON QLD 4006.

General Advertisment for Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates

Further Information
Volunteers required to participate in clinical trials of new drugs and vaccines. - Healthy Females and Males.
- Aged between 18 to 85 years.
- BMI between 18 and 32.


- Screening medical.
- In addition some trials may require a number of clinic visit for 1 – 2 hour periods and or in-house stays at Q-Pharm clinic from 12 hours or as long as 7 days. 
 -Trial dependent.

Please register via the 'Volunteer Registration' section under the 'Volunteers' tab.


Healthy Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates
QP13C15 Hendra Virus

- Males and Females 18 to 50 years of age

- Must not have had close, unprotected exposure to sick horses within 4 weeks prior to medical screening.

- Must not have received or plan to receive a vaccination 1 month prior to commencement of trial.

- Must not be on any prescription or non prescription drugs, supplements or protein drinks 2 weeks prior to commencement of trial.

- Able to attend a medical screening visit.

- 3 night confinement period and 10 follow up visits to the clinic. .

- Length of trial 5 months.

Commencement dates for Cohort 1A 14th April and Cohort 1B for 5th May, 2015

Further cohorts available in June and July, 2015, dates to be advised.

QP14C07 Male Pattern Baldness

- Males only 18 to 60 years of age

- Not have used any scalp hair growth products within 12 weeks of commencement  of trial

- Must now have had a clinical diagnosis of alopecia areata

- Must not have a current skin disease

- Must now have had use of finasteride, dutasteride, minoxidil within 12 weeks of commencement of trial


- Able to attend a medical screening visit

- 15 consecutive visits to the clinic, 2 of these visits will last approx. 12 hours

- 1 final visit

Trial is now closed to further recruitment.

Further cohorts available, dates still to be confirmed.


New Treatment For Respiratory Tract Infections


- Males and Females

- 18 - 55 years of age inclusive

- Females must be post menopausal or surgically sterile.

-Non Smoker

- Able to attend 1 x 9 night confinement

- 2 x Follow up visits (approx. 1 hour each)

Recruiting Now

Commencement Date for Cohort 8: Monday 27th April, 2015, start of 9 day confinement period.

Commencement Dates for Cohort 9: Monday 18th May, 2015, start of 9 day confinement period.


QP13C02 New treatment for malaria

- Healthy and between the ages of 18 to 55 years.

- Males or Post Menopausal Women

- Practicing effective contraception.

- Currently on no medications

- Willing to cease smoking and limit alcohol consumption.

Able to attend a 3 night stay and 7 follow up visits. 

Cohort 9A Recruiting Soon


Commencement Dates 13th May, 2015

QP14C09 Research for new muscle relaxant
- Healthy Males between the ages 18 - 50 years.
- Practicing effective contraception with their partners.
- Currently on no medications.
- If a smoker must smoke < 5 a day and able to abstain from screening until end of confinement.
- Cannot participate in activity/sport which requires high load and intensity to the foot whilst on the study.
Able to attend 2 medicals, 1 pre-dose visit, 1 x 48 hour confinement period and 5 follow up outpatient visits over a 3 month period.

Cohort 3 Recruiting Now.

Commencement dates:

Monday 13th April, 2015. 

 Further cohorts available, dates yet to be confirmed.

QP14C17 Overweight Type 2 Diabetics

- Males and Females

-Aged 18 - 65 years

- BMI 30 - 60

- Type 2 diabetic controlled with diet and exercise along and/or with stable treatment


- A medical screening visit.

- At least 12 outpatient visits over a year.

Recruiting Now.

Various dosing commencement dates available, can be discussed at time of call.

QP14C12 New treatment for Malaria

- Males Only aged 18-55 years.

- Generally healthy

-Must not have travelled or lived > 2 weeks in a malaria endemic country last 12 months.

- Must not have a history of malaria or completed a previous malaria trial.

- Social smokers must be willing to cease smoking for the duration of the trial.

- Must not be on prescription medications 4 weeks prior to commencement of the trial or over the counter supplements 14 days prior to the commencement of the trial.


Able to attend a 2 night confinement and a 5 hour confinement.

- Approximately 20 follow up visits.

- Some AM/PM visits

Cohort  2 Now Recruiting. 

Commencement date 22nd April, 2015


Patient Based Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates
QP14C16 HSV-2 Vaccine

- Males and Females

- 18 - 50 years old

- HSV-2 Positive

- No anti viral medications

- No Cancer treatment




- 13 month trial period

- Able to attend a medical Screening Visit

- 3 x Vaccination Visits plus a booster vaccination at 6 month

- 12 x outpatient visits

- 5 x phone calls


- To commence March 2015.


All studies at Q-Pharm are conducted under Australian and International guidelines for medical research under the approval of a Human Research Ethics Committee that complies with the strict guidelines as set by the National Health and Medical Research Council. Participation in a trial is dependent on fulfilment of trial specific criteria and overseas visitors require appropriate visas for trial participation.